Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1320096.RAvBwsvQRXPUa-Y7OqzqclukKJnMo2PdQnHW6G0JLsHBc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1320096.RAvBwsvQRXPUa-Y7OqzqclukKJnMo2PdQnHW6G0JLsHBc130_assertion type Assertion NP1320096.RAvBwsvQRXPUa-Y7OqzqclukKJnMo2PdQnHW6G0JLsHBc130_head.
- NP1320096.RAvBwsvQRXPUa-Y7OqzqclukKJnMo2PdQnHW6G0JLsHBc130_assertion description "[Negative expression of nm23-H1, positive expression of c-erbB-2, and a combined nm23-H1-negative and c-erbB-2-positive expression were associated with a high incidence of lymph node involvement (P = 0.36, P = 0.0015, P = 0.0055, respectively) and with poor prognosis of patients (P = 0.034, P = 0.014, P = 0.00008, respectively) with adenocarcinoma of the uterine cervix, but not in those with squamous cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1320096.RAvBwsvQRXPUa-Y7OqzqclukKJnMo2PdQnHW6G0JLsHBc130_provenance.
- NP1320096.RAvBwsvQRXPUa-Y7OqzqclukKJnMo2PdQnHW6G0JLsHBc130_assertion evidence source_evidence_literature NP1320096.RAvBwsvQRXPUa-Y7OqzqclukKJnMo2PdQnHW6G0JLsHBc130_provenance.
- NP1320096.RAvBwsvQRXPUa-Y7OqzqclukKJnMo2PdQnHW6G0JLsHBc130_assertion SIO_000772 7736397 NP1320096.RAvBwsvQRXPUa-Y7OqzqclukKJnMo2PdQnHW6G0JLsHBc130_provenance.
- NP1320096.RAvBwsvQRXPUa-Y7OqzqclukKJnMo2PdQnHW6G0JLsHBc130_assertion wasDerivedFrom befree-2016 NP1320096.RAvBwsvQRXPUa-Y7OqzqclukKJnMo2PdQnHW6G0JLsHBc130_provenance.
- NP1320096.RAvBwsvQRXPUa-Y7OqzqclukKJnMo2PdQnHW6G0JLsHBc130_assertion wasGeneratedBy ECO_0000203 NP1320096.RAvBwsvQRXPUa-Y7OqzqclukKJnMo2PdQnHW6G0JLsHBc130_provenance.